ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
94 541,63
-2,74%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vericel Corporation (VCEL)

  7. Vericel Corporation (VCEL) Actualités

VCEL

Vericel (VCEL)

Vericel Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VCEL
DateHeureSourceTitreSymboleSociété
05/12/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCELVericel Corporation
04/12/202416h37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VCELVericel Corporation
14/11/202412h19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VCELVericel Corporation
07/11/202414h48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCELVericel Corporation
07/11/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCELVericel Corporation
07/11/202413h55GlobeNewswire Inc.Vericel Reports Third Quarter 2024 Financial ResultsNASDAQ:VCELVericel Corporation
24/10/202414h30GlobeNewswire Inc.Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024NASDAQ:VCELVericel Corporation
29/08/202415h17GlobeNewswire Inc.Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024NASDAQ:VCELVericel Corporation
26/08/202413h45GlobeNewswire Inc.Vericel Announces FDA Approval and Commercial Availability of MACI ArthroNASDAQ:VCELVericel Corporation
16/08/202422h06Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:VCELVericel Corporation
15/08/202422h05GlobeNewswire Inc.Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal BurnsNASDAQ:VCELVericel Corporation
07/08/202414h30GlobeNewswire Inc.Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024NASDAQ:VCELVericel Corporation
01/08/202413h55GlobeNewswire Inc.Vericel Reports Second Quarter 2024 Financial ResultsNASDAQ:VCELVericel Corporation
22/07/202414h30GlobeNewswire Inc.Vericel Announces Appointment of Karen Mahoney as Chief Human Resources OfficerNASDAQ:VCELVericel Corporation
18/07/202414h30GlobeNewswire Inc.Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024NASDAQ:VCELVericel Corporation
11/06/202414h30GlobeNewswire Inc.Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024NASDAQ:VCELVericel Corporation
22/05/202414h30GlobeNewswire Inc.Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024NASDAQ:VCELVericel Corporation
08/05/202413h55GlobeNewswire Inc.Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial GuidanceNASDAQ:VCELVericel Corporation
24/04/202414h30GlobeNewswire Inc.Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024NASDAQ:VCELVericel Corporation
29/02/202415h04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCELVericel Corporation
29/02/202413h55GlobeNewswire Inc.Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial GuidanceNASDAQ:VCELVericel Corporation
27/02/202414h30GlobeNewswire Inc.Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024NASDAQ:VCELVericel Corporation
15/02/202414h30GlobeNewswire Inc.Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024NASDAQ:VCELVericel Corporation
14/02/202413h42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VCELVericel Corporation
13/02/202412h01Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:VCELVericel Corporation
05/02/202414h30GlobeNewswire Inc.Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024NASDAQ:VCELVericel Corporation
09/01/202413h55GlobeNewswire Inc.Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial ResultsNASDAQ:VCELVericel Corporation
03/01/202414h30GlobeNewswire Inc.Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024NASDAQ:VCELVericel Corporation
08/12/202322h39Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VCELVericel Corporation
08/11/202313h55GlobeNewswire Inc.Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial GuidanceNASDAQ:VCELVericel Corporation
 Showing the most relevant articles for your search:NASDAQ:VCEL

Dernières Valeurs Consultées

EU
AI
Air Liquide
EU
ML
Michelin
COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
EU
CS
Axa
COIN
ADAUSD
Cardano
EU
PX1
CAC 40
EU
CAP
Capgemini
NASDAQ
AAPL
Apple
EU
VIV
Vivendi
EU
MC
Lvmh Moet Hennessy Louis...
EU
RNO
Renault
EU
SGO
Cie de SaintGobain
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés